Officials at a major journal discussed a professor’s alleged anti-vaccine Twitter activity when considering whether to publish his paper challenging the claim that Pfizer’s vaccine was 95 percent effective, newly disclosed emails show.
The Lancet journal ultimately rejected the rebuttal paper.
